PIRS Tingkat bathi reged Pieris Pharmaceuticals Inc

Lambang korporat lan logo Pieris (PIRS)

The gross margin as a percentage of revenue demonstrates efficiency dynamics, where the value 0.00 reflects the metric's balance for Pieris Pharmaceuticals (PIRS). The business model relies on protein licensing to minimize production costs. However, liquidity shortages and capital burn complicate development. Stability is provided by the Anticalin platform developments and partnerships with industry behemoths in the US and Germany to combat oncology.

PIRS Rentabilitas reged Pieris Pharmaceuticals, Inc. (04.07.2022 - 20.11.2026)

Rincian analitis lan laporan data perusahaan Pieris (PIRS)

- nilai saham lan prakiraan konsensus rega:
Produk sing diprodhuksi Pieris Pharmaceuticals Inc

Gross margin determines the portion of revenue remaining after covering direct production costs, serving as a fundamental indicator of operational efficiency. Analyzing this metric through gross profit margin trends allows for an assessment of the business's ability to generate profit before accounting for administrative expenses. For Pieris Pharmaceuticals (PIRS), this figure reflects the commercial value of anti-kalin development within asthma and oncology therapy partnerships.

Pesaing langsung

Margin bathi reged Haleon PLC (HLN)|Tingkat bathi miturut bathi reged KVUE|Margin bathi reged Verona Pharma Inc. VRNA|Margin reged MENS|Ligand Pharmaceuticals - Rentabilitas dodolan reged|Rentabilitas reged Amneal AMRX|Margin dodolan reged Perrigo Company PLC|Alvotech Biopharmaceuticals - Margin reged|Rentabilitas dodolan miturut bathi reged Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Rentabilitas reged|anipharmaceuticals.com - Tingkat bathi reged|Tingkat bathi miturut bathi reged MNKD|AMPH: Tingkat bathi reged|Rentabilitas reged pacira.com (PCRX)|Margin reged ARS Pharma (SPRY)|Theravance Biopharma - Tingkat bathi miturut bathi reged|Rasio bathi reged AQST (Aquestive Therapeutics)|SCPH: Tingkat bathi miturut bathi reged|Margin bathi reged Tectonic Therapeutic|TNXP: Margin reged|SXT China (SXTC) - Margin reged|Rentabilitas reged eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas dodolan miturut bathi reged|Rentabilitas reged Invizyne (EXOZ)|ORMP - Margin bathi reged|Margin reged ENTX (Entera Bio)|Margin dodolan reged MindWalk Therapeutics|ABVC: Tingkat bathi miturut bathi reged|CPIX - Margin reged|QNTM (Quantum BioPharma) - Tingkat bathi miturut bathi reged|Tingkat bathi adhedhasar bathi reged FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin reged|Margin reged ranitherapeutics.com|Rentabilitas reged Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan reged|lexariabioscience.com - Tingkat bathi miturut bathi reged|Margin reged Pulmatrix Inc PULM|Pheton Holdings - Margin reged|Tingkat bathi adhedhasar bathi reged APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas reged|Margin bathi reged Impact BioMedical, Inc. (IBO)|Rentabilitas reged TNF Pharma|YCBD: Tingkat bathi reged|Margin reged PRFX|CYTO - Margin bathi reged|Rentabilitas reged Lipella LIPO|Rasio bathi reged OPTN (OptiNose, Inc.)|PROC - Rentabilitas reged|Tingkat bathi adhedhasar bathi reged PTPI|QLI: Margin reged|Margin bathi reged ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Margin reged